Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts

Cell and Tissue Research

Volumn 342, Issue 2, 2010, Pages 213-220

  Tachi, Keita ^a   Takami, Masamichi ^a   Zhao, Baohong ^a   Mochizuki, Ayako ^a   Yamada, Atsushi ^a   Miyamoto, Yoichi ^a   Inoue, Tomio ^a   Baba, Kazuyoshi ^a   Kamijo, Ryutaro ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic protein (BMP) 2; Mouse (ddy); Osteoblasts; Osteoclasts; Receptor activator of NF B ligand (RANKL)

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCITRIOL; COLONY STIMULATING FACTOR 1; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; RECOMBINANT COLONY STIMULATING FACTOR 1; RECOMBINANT PROTEIN; VITAMIN D RECEPTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; COCULTURE; CONTROLLED STUDY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 78649329687     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-010-1052-y     Document Type: Article

References (24)

1. M Asagiri H Takayanagi 2007 The molecular understanding of osteoclast differentiation Bone 40 251 264 1:CAS:528:DC%2BD2sXmtVCrtA%3D%3D 10.1016/j.bone.2006.09.023 17098490 (Pubitemid 46054562)
2. WJ Boyle WS Simonet DL Lacey 2003 Osteoclast differentiation and activation Nature 423 337 342 1:CAS:528:DC%2BD3sXjs1ynu7g%3D 10.1038/nature01658 12748652 (Pubitemid 40852708)
3. T Katagiri N Takahashi 2002 Regulatory mechanisms of osteoblast and osteoclast differentiation Oral Dis 8 147 159 1:STN:280:DC%2BD38zmtlCrsQ%3D%3D 10.1034/j.1601-0825.2002.01829.x 12108759 (Pubitemid 34535063)
4. M Koide Y Murase K Yamato T Noguchi N Okahashi T Nishihara 1999 Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1α through upregulation of osteoclast differentiation factor and cyclooxygenase-2 Biochem Biophys Res Commun 259 97 102 1:CAS:528: DyaK1MXjtFKhtLc%3D 10.1006/bbrc.1999.0715 10334922 (Pubitemid 29264000)
5. T Komori 2006 Regulation of osteoblast differentiation by transcription factors J Cell Biochem 99 1233 1239 1:CAS:528:DC%2BD28Xht1ahsLbP 10.1002/jcb.20958 16795049
6. YY Kong H Yoshida I Sarosi HL Tan E Timms C Capparelli S Morony AJ Oliveira-dos-Santos G Van A Itie W Khoo A Wakeham CR Dunstan DL Lacey TW Mak WJ Boyle JM Penninger 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature 397 315 323 1:CAS:528:DyaK1MXhtVOqs7w%3D 10.1038/16852 9950424 (Pubitemid 29061638)
7. A Mizuno N Amizuka K Irie A Murakami N Fujise T Kanno Y Sato N Nakagawa H Yasuda S Mochizuki T Gomibuchi K Yano N Shima N Washida E Tsuda T Morinaga K Higashio H Ozawa 1998 Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin Biochem Biophys Res Commun 247 610 615 1:CAS:528:DyaK1cXkt12htr8%3D 10.1006/bbrc.1998.8697 9647741 (Pubitemid 28418439)
8. A Mizuno T Kanno M Hoshi O Shibata K Yano N Fujise M Kinosaki K Yamaguchi E Tsuda A Murakami H Yasuda K Higashio 2002 Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis J Bone Miner Metab 20 337 344 1:CAS:528:DC%2BD38XoslSnsbc%3D 10.1007/s007740200049 12434161 (Pubitemid 40645655)
9. K Mori R Kitazawa T Kondo S Maeda A Yamaguchi S Kitazawa 2006 Modulation of mouse RANKL gene expression by Runx2 and PKA pathway J Cell Biochem 98 1629 1644 1:CAS:528:DC%2BD28XnvFWrsr4%3D 10.1002/jcb.20891 16598781 (Pubitemid 44141865)
10. M Notoya E Otsuka A Yamaguchi H Hagiwara 2004 Runx-2 is not essential for the vitamin D-regulated expression of RANKL and osteoprotegerin in osteoblastic cells Biochem Biophys Res Commun 324 655 660 1:CAS:528:DC%2BD2cXotlCms7g%3D 10.1016/j.bbrc.2004.09.101 15474477 (Pubitemid 39345566)
11. 3 or parathyroid hormone. J Biol Chem 274 19301 19308 10.1074/jbc.274.27.19301 10383440 (Pubitemid 29314134)
12. E Otsuka M Notoya H Hagiwara 2003 Treatment of myoblastic C2C12 cells with BMP-2 stimulates vitamin D-induced formation of osteoclasts Calcif Tissue Int 73 72 77 1:CAS:528:DC%2BD3sXmsFGltbo%3D 10.1007/s00223-002-1071-0 14506957 (Pubitemid 37022082)
13. M Sato Y Nakamichi M Nakamura N Sato T Ninomiya A Muto H Nakamura H Ozawa Y Iwasaki E Kobayashi M Shimizu HF DeLuca N Takahashi N Udagawa 2007 New 19-nor-(20S)-1α, 25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro Bone 40 293 304 1:CAS:528:DC%2BD2sXmtVCruw%3D%3D 10.1016/j.bone.2006.09.007 17070129 (Pubitemid 46054563)
14. WS Simonet DL Lacey CR Dunstan M Kelley MS Chang R Luthy HQ Nguyen S Wooden L Bennett T Boone G Shimamoto M DeRose R Elliott A Colombero HL Tan G Trail J Sullivan E Davy N Bucay L Renshaw-Gegg TM Hughes D Hill W Pattison P Campbell S Sander G Van J Tarpley P Derby R Lee WJ Boyle 1997 Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 309 319 1:CAS:528:DyaK2sXislCgtLc%3D 10.1016/S0092-8674(00)80209-3 9108485
15. T Suda E Jimi I Nakamura N Takahashi 1997 Role of 1α, 25-dihydroxyvitamin D3 in osteoclast differentiation and function Methods Enzymol 282 223 235 1:CAS:528:DyaK2sXntFagu74%3D 10.1016/S0076-6879(97)82110-6 9330291 (Pubitemid 27412778)
16. T Suda N Takahashi N Udagawa E Jimi MT Gillespie TJ Martin 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families Endocr Rev 20 345 357 1:CAS:528:DyaK1MXktVaqtLg%3D 10.1210/er.20.3.345 10368775 (Pubitemid 30649812)
17. N Takahashi T Akatsu N Udagawa T Sasaki A Yamaguchi JM Moseley TJ Martin T Suda 1988 Osteoblastic cells are involved in osteoclast formation Endocrinology 123 2600 2602 1:CAS:528:DyaL1cXmt1aquro%3D 10.1210/endo-123-5-2600 2844518
18. N Takahashi H Yamana S Yoshiki GD Roodman GR Mundy SJ Jones A Boyde T Suda 1988 Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures Endocrinology 122 1373 1382 1:CAS:528:DyaL1cXhvVSqs74%3D 10.1210/endo-122-4-1373 3345718
19. 3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells Endocrinology 123 1504 1510 1:CAS:528:DyaL1cXlsVeht7k%3D 10.1210/endo-123-3-1504 2841098
20. S Takeda T Yoshizawa Y Nagai H Yamato S Fukumoto K Sekine S Kato T Matsumoto T Fujita 1999 Stimulation of osteoclast formation by 1, 25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice Endocrinology 140 1005 1008 1:CAS:528:DyaK1MXntl2lug%3D%3D 10.1210/en.140.2.1005 9927335 (Pubitemid 29058242)
21. BR Wong J Rho J Arron E Robinson J Orlinick M Chao S Kalachikov E Cayani FS Bartlett 3rd WN Frankel SY Lee Y Choi 1997 TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells J Biol Chem 272 25190 25194 1:CAS:528:DyaK2sXms1ehsbo%3D 10.1074/jbc.272.40.25190 9312132 (Pubitemid 27415705)
22. N Yamamoto S Akiyama T Katagiri M Namiki T Kurokawa T Suda 1997 Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts Biochem Biophys Res Commun 238 574 580 1:CAS:528:DyaK2sXmsVGktLk%3D 10.1006/bbrc.1997.7325 9299554 (Pubitemid 27464430)
23. Y Yamamoto N Udagawa S Matsuura Y Nakamichi H Horiuchi A Hosoya M Nakamura H Ozawa K Takaoka JM Penninger T Noguchi N Takahashi 2006 Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-κB ligand Endocrinology 147 3366 3374 1:CAS:528: DC%2BD28XmtlOrs7s%3D 10.1210/en.2006-0216 16627581 (Pubitemid 43901128)
24. T Yoshizawa Y Handa Y Uematsu S Takeda K Sekine Y Yoshihara T Kawakami K Arioka H Sato Y Uchiyama S Masushige A Fukamizu T Matsumoto S Kato 1997 Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning Nat Genet 16 391 396 1:CAS:528:DyaK2sXkvFCht74%3D 10.1038/ng0897-391 9241280 (Pubitemid 27323308)